Apply to the Developmental Pathway Gap Fund to address a single-step evidence gap and de-risk the development of a new medicine, medical device, diagnostic test, or other medical intervention.
To apply, you must be based at a research organisation eligible for MRC funding.
Apply for funding to run a high throughput screen (HTS) using AstraZeneca’s compound library and screening robots.
Two funding opportunities per year with changing highlights. This funding opportunity will have a highlight on new targets related to pain or women’s health (including conditions related to metabolic disorders).